Drug Approval | May 14, 2022
Zydus launches Bemdac to treat LDL-Cholesterol
It is a new class of drug that treats uncontrolled LDLCholesterol, despite the use of a maximum tolerated dose of statins
It is a new class of drug that treats uncontrolled LDLCholesterol, despite the use of a maximum tolerated dose of statins
The two-dose regimen for ZyCoV-D was tested in 3100 healthy volunteers more than 12 years of age
Zydus unveils its ‘innovation and care’ centric corporate brand identity
Nelarabine is in a class of medications called antimetabolites
Subscribe To Our Newsletter & Stay Updated
